Inventor · disambiguated record
Heather Mcfarlane
Also filed as: MCFARLANE HEATHER
5 granted patents·3 pending applications·0 citations·filing 2016–2024
61Inventor score
Files withNANTBIO INC8
Top patents by PatentIndex Score
8 records- 0174US2024360191A1Targeted IL-12 Treatments and Methods to Stimulate haNK and NK92mi CellsNANTBIO INC·Filed 2024·Application pending·0 cites
- 0268US10736884B2Compositions and methods of Rit1 inhibitionNANTBIO INC·Filed 2019·Granted Aug 11, 2020·0 cites·1 claims
- 0366US2024124598A1Anti-CD30 monoclonal antibodies and chimeric antigen receptorsNANTBIO INC·Filed 2023·Application pending·0 cites
- 0465US11814436B2Anti-CD30 monoclonal antibodies and chimeric antigen receptorsNANTBIO INC·Filed 2022·Granted Nov 14, 2023·0 cites·18 claims
- 0564US12098177B2Targeted IL-12 treatments and methods to stimulate haNK and NK92mi cellsNANTBIO INC·Filed 2019·Granted Sep 24, 2024·0 cites·17 claims
- 0658US10525040B2Compositions and methods of Rit1 inhibitionNANTBIO INC·Filed 2016·Granted Jan 7, 2020·0 cites·5 claims
- 0753US2021061871A1Modified N-810 and Methods ThereforNANTBIO INC·Filed 2020·Application pending·0 cites
- 0841US10487078B2Compositions and methods of targeting mutant K-RASNANTBIO INC·Filed 2016·Granted Nov 26, 2019·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Heather Mcfarlane files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →